» Articles » PMID: 3622506

Clostridium Difficile-associated Diarrhoea in Uremic Patients

Overview
Specialty Microbiology
Date 1987 Jun 1
PMID 3622506
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

An outbreak of 94 episodes of Clostridium difficile-associated diarrhoea in 62 patients in a nephrology ward over a two-year period was investigated. Quantitative stool cultures were performed on ten uremic patients not on antibiotics and without diarrhoea and on ten healthy controls. All diarrhoeal episodes were associated with Clostridium difficile, and no other bacterial pathogens were isolated. Thirty-two relapses occurred in 16 patients, fourteen of the relapses without preceding antibiotic exposure. Clostridium difficile could not be isolated from the environment of the patients. Uremic patients, who had a significantly increased number of Clostridium spp. in their stools, are predisposed to Clostridium difficile infections.

Citing Articles

Development of a Prediction Model to Identify the Risk of Infection in Hospitalized Patients Receiving at Least One Dose of Antibiotics.

Alamri A, Bin Abbas A, Al Hassan E, Almogbel Y Pharmacy (Basel). 2024; 12(1).

PMID: 38392945 PMC: 10892393. DOI: 10.3390/pharmacy12010037.


Clostridioides difficile Infection in Patients with Chronic Kidney Disease: A Systematic Review.

Mihaescu A, Augustine A, Khokhar H, Zafran M, Masood S, Gilca-Blanariu G Biomed Res Int. 2021; 2021:5466656.

PMID: 34557546 PMC: 8455215. DOI: 10.1155/2021/5466656.


Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD.

Haarhaus M, Brandenburg V, Kalantar-Zadeh K, Stenvinkel P, Magnusson P Nat Rev Nephrol. 2017; 13(7):429-442.

PMID: 28502983 DOI: 10.1038/nrneph.2017.60.


Excess Mortality Attributable to Clostridium difficile and Risk Factors for Infection in an Historic Cohort of Hospitalised Patients Followed Up in the United Kingdom Death Register.

Reacher M, Verlander N, Roddick I, Trundle C, Brown N, Farrington M PLoS One. 2016; 11(3):e0149983.

PMID: 26999613 PMC: 4801172. DOI: 10.1371/journal.pone.0149983.


Advanced chronic kidney disease: a strong risk factor for Clostridium difficile infection.

Kim S, Seo M, Lee J, Kim K, Cho E, Kim M Korean J Intern Med. 2016; 31(1):125-33.

PMID: 26767866 PMC: 4712416. DOI: 10.3904/kjim.2016.31.1.125.


References
1.
Poxton I, Byrne M . Immunological analysis of the EDTA-soluble antigens of Clostridium difficile and related species. J Gen Microbiol. 1981; 122(1):41-6. DOI: 10.1099/00221287-122-1-41. View

2.
Bartlett J, Tedesco F, Shull S, Lowe B, Chang T . Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis. Gastroenterology. 1980; 78(3):431-4. View

3.
Ellis M, Watson B, Milewski P, Jones G . Clostridium difficile colitis unassociated with antibiotic therapy. Br J Surg. 1983; 70(4):242-3. DOI: 10.1002/bjs.1800700420. View

4.
George W, Volpicelli N, Stiner D, Richman D, Liechty E, Mok H . Relapse of pseudomembranous colitis after vancomycin therapy. N Engl J Med. 1979; 301(8):414-5. DOI: 10.1056/NEJM197908233010806. View

5.
Milligan D, Kelly J . Pseudomembranous colitis in a leukaemia unit: a report of five fatal cases. J Clin Pathol. 1979; 32(12):1237-43. PMC: 1145943. DOI: 10.1136/jcp.32.12.1237. View